article thumbnail

Top Life Science News and Trends in 2023 at Xtalks

XTalks

In 2023, there were significant advancements and notable trends in the life sciences. Xtalks compiled a list of its top life science news and trends of 2023, which provided readers with the latest developments, information and expert insights across life science industries, including pharma, biotech and medical device.

article thumbnail

10 Trends and Statistics for Clinical Trials in 2023

XTalks

It is clear that the clinical research landscape continues to expand at a substantial rate. Growing Complexity of Clinical Trials Research teams are increasingly dealing with complex clinical trial designs and clinical research complexity.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Digital tools driving innovative clinical trials

pharmaphorum

Thread is helping customers create and utilise digital endpoints in therapeutic areas like dermatology, respiratory, and CNS applications where the voice data capture is becoming important. Dr Steven LeBoeuf , founder, Valencell, US, a market leader in the innovative science of wearable biometric devices that deliver enhanced health results.

article thumbnail

Eflornithine (Iwilfin) Finally Gets Approval in a Cancer Indication with FDA Nod for High-Risk Neuroblastoma

XTalks

However, its uses expanded over the years into other indications, ranging from parasitic infection to dermatology. In a statement , USWM said it partnered with the Beat Childhood Cancer Research Consortium at Penn State University, which “conducted the preclinical and clinical research to help advance this vital therapy.

article thumbnail

BioSpace Movers & Shakers, Dec. 18

The Pharma Data

Martin Carter Professor in Clinical Investigation and Head of the Laboratory of Investigative Dermatology at The Rockefeller University and Weinblatt is the co-director of Clinical Rheumatology at the Brigham and Women’s Hospital. Recro – CDMO company Recro announced David Enloe as its new president and CEO.